UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
[X] |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2002 |
|||
OR |
||||
[_] |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO |
|||
COMMISSION FILE NUMBER 000-26124
IXYS CORPORATION
(Exact name of registrant as specified in its charter)
| DELAWARE (State or other jurisdiction of incorporation or organization) |
77-0140882 (IRS Employer Identification No.) |
3540 BASSETT STREET
SANTA CLARA, CALIFORNIA 95054-2704
(Address of principal executive offices and Zip Code)
(408) 982-0700
(Registrants telephone number, including area code)
| Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. |
Yes [X] No [_]
THE NUMBER OF SHARES OF THE REGISTRANTS COMMON STOCK, $0.01 PAR VALUE, OUTSTANDING AS OF AUGUST 12, 2002, WAS 31,826,692.
IXYS CORPORATION
INDEX
| PART I - FINANCIAL INFORMATION | 1 | |||||||
| ITEM 1. | FINANCIAL STATEMENTS | 1 | ||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | 1 | |||||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | 2 | |||||||
| CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME | 3 | |||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | 4 | |||||||
| NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | 5 | |||||||
| ITEM 2. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION | 12 | ||||||
| ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 24 | ||||||
| PART II - OTHER INFORMATION | 25 | |||||||
| ITEM 1. | LEGAL PROCEEDINGS | 25 | ||||||
| ITEM 2. | CHANGES IN SECURITIES AND USE OF PROCEEDS | 26 | ||||||
| ITEM 3. | DEFAULTS UPON SENIOR SECURITIES | 26 | ||||||
| ITEM 4. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS | 26 | ||||||
| ITEM 5. | OTHER INFORMATION | 26 | ||||||
| ITEM 6. | EXHIBITS AND REPORTS ON FORM 8-K | 26 | ||||||
| SIGNATURES | 27 | |||||||
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
IXYS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
| June 30, | March 31, | ||||||||||
| 2002 | 2002 | ||||||||||
| (unaudited) | |||||||||||
ASSETS |
|||||||||||
Current assets: |
|||||||||||
Cash and cash equivalents |
$ | 42,851 | $ | 32,111 | |||||||
Restricted cash |
2,651 | 205 | |||||||||
Accounts receivable, net of allowance for doubtful accounts
of $1,875 at June 30, 2002 and $1,045 at March 31, 2002 |
23,086 | 16,697 | |||||||||
Inventories |
55,395 | 46,317 | |||||||||
Prepaid expenses and other current assets |
2,453 | 596 | |||||||||
Deferred income taxes |
2,810 | 2,553 | |||||||||
Total current assets |
129,246 | 98,479 | |||||||||
Plant and equipment, net |
34,267 | 19,238 | |||||||||
Other assets |
24,067 | 4,828 | |||||||||
Deferred income taxes |
2,463 | 2,015 | |||||||||
Total assets |
$ | 190,043 | $ | 124,560 | |||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
|||||||||||
Current liabilities: |
|||||||||||
Current portion of capitalized lease obligations |
$ | 2,795 | $ | 2,391 | |||||||
Current portion of notes payable to bank |
769 | 700 | |||||||||
Accounts payable |
10,940 | 5,606 | |||||||||
Accrued expenses and other liabilities |
12,231 | 8,383 | |||||||||
Total current liabilities |
26,735 | 17,080 | |||||||||
Capitalized lease obligations, net of current portion |
5,687 | 4,770 | |||||||||
Loan payable |
136 | 118 | |||||||||
Pension liabilities |
8,422 | 7,373 | |||||||||
Total liabilities |
40,980 | 29,341 | |||||||||
Commitments and contingencies (Note 8) |
|||||||||||
Stockholders Equity
|
|||||||||||
Preferred
stock, $0.01 par value: Authorized: 5,000,000 shares; none issued and outstanding |
|||||||||||
Common
stock, $0.01 par value: Authorized: 80,000,000 shares Issued and outstanding: 31,838,315 shares at June 30, 2002 and 26,827,192 shares at March 31, 2002 |
318 | 268 | |||||||||
Additional paid-in capital |
144,319 | 92,785 | |||||||||
Notes receivable from stockholders |
(853 | ) | (853 | ) | |||||||
Retained earnings |
5,113 | 5,827 | |||||||||
Less cost of treasury stock: 75,000 shares at June 30, 2002 and at March 31, 2002 |
(445 | ) | (445 | ) | |||||||
Accumulated
other comprehensive income (loss) |
611 | (2,363 | ) | ||||||||
Total stockholders equity |
149,063 | 95,219 | |||||||||
Total liabilities and stockholders equity |
$ | 190,043 | $ | 124,560 | |||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
1
IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
| Three Months Ended | |||||||||||
| June 30, | |||||||||||
| 2002 | 2001 | ||||||||||
| (unaudited) | |||||||||||
Net revenues |
$ | 27,437 | $ | 25,605 | |||||||
Cost of goods sold |
19,978 | 17,299 | |||||||||
Gross profit |
7,459 | 8,306 | |||||||||
Operating expenses: |
|||||||||||
Research, development and engineering |
2,186 | 1,181 | |||||||||
Selling, general and administrative |
5,115 | 3,419 | |||||||||
Amortization
of acquired intangible assets and goodwill |
90 | 58 | |||||||||
Total operating expenses |
7,391 | 4,658 | |||||||||
Operating income |
68 | 3,648 | |||||||||
Interest income |
203 | 341 | |||||||||
Interest expense |
(39 | ) | (195 | ) | |||||||
Other (expense) income, net |
(1,352 | ) | (1,238 | ) | |||||||
Income (loss) before income tax provision (benefit) |
(1,120 | ) | 2,556 | ||||||||
Benefit from (provision for) income tax |
406 | (970 | ) | ||||||||
Net income (loss) |
$ | (714 | ) | $ | 1,586 | ||||||
Net income (loss) per share basic |
$ | (0.03 | ) | $ | 0.06 | ||||||
Weighted
average shares used in per share calculation basic |
27,999 | 26,690 | |||||||||
Net income (loss) per share diluted |
$ | (0.03 | ) | $ | 0.05 | ||||||
Weighted
average shares used in per share calculation diluted |
27,999 | 29,180 | |||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(in thousands)
| Three Months Ended | |||||||||
| June 30, | |||||||||
| 2002 | 2001 | ||||||||
| (unaudited) | |||||||||
Net income (loss) |
$ | (714 | ) | $ | 1,586 | ||||
Other comprehensive income: |
|||||||||
Foreign currency translation adjustments |
2,974 | 75 | |||||||
Comprehensive income |
$ | 2,260 | $ | 1,661 | |||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
| Three Months Ended | |||||||||
| June 30, | |||||||||
| 2002 | 2001 | ||||||||
| (unaudited) | |||||||||
Cash flows from operating activities: |
|||||||||
Net income (loss) |
$ | (714 | ) | $ | 1,586 | ||||
Adjustments
to reconcile net income to net cash provided by (used in) operating activities: |
|||||||||
Depreciation |
1,409 | 816 | |||||||
Amortization
of intangible assets and goodwill |
90 | 58 | |||||||
Provision for doubtful accounts |
291 | (151 | ) | ||||||
Provision for excess and obsolete inventory |
| 786 | |||||||
Gain on disposal of assets |
| (5 | ) | ||||||
Deferred income taxes |
(660 | ) | | ||||||
Loss on foreign currency transactions |
38 | (159 | ) | ||||||
Changes in operating assets and liabilities : |
|||||||||
Accounts receivable |
(1,307 | ) | 2,299 | ||||||
Inventories |
2,185 | (4,282 | ) | ||||||
Prepaid expenses and other current assets |
(986 | ) | (16 | ) | |||||
Other assets |
(889 | ) | (373 | ) | |||||
Accounts payable |
1,246 | (3,580 | ) | ||||||
Accrued expenses and other liabilities |
(759 | ) | (419 | ) | |||||
Pension liabilities |
123 | 54 | |||||||
Net cash provided by (used in) operating activities |
67 | (3,386 | ) | ||||||
Cash flows from investing activities: |
|||||||||
Restricted cash |
(114 | ) | (17 | ) | |||||
Net cash acquired in acquisition of Clare, Inc. |
7,906 | | |||||||
Cash
received for tax refund claims acquired from Clare |
2,500 | | |||||||
Proceeds from disposal of assets |
| 5 | |||||||
Purchase of plant and equipment |
(63 | ) | (638 | ) | |||||
Net cash provided by (used in) investing activities |
10,229 | (650 | ) | ||||||
Cash flows from financing activities: |
|||||||||
Proceeds from capital lease obligations |
| 75 | |||||||
Principal payments on capital lease obligations |
(722 | ) | (672 | ) | |||||
Repayment of notes payable to bank |
| (48 | ) | ||||||
Proceeds from exercise of options |
68 | 169 | |||||||
Proceeds from issuance of shares under ESPP |
112 | 194 | |||||||
Net cash used in financing activities |
(542 | ) | (282 | ) | |||||
Effect of foreign exchange rate fluctuations on cash and cash equivalents |
986 | (351 | ) | ||||||
Net increase (decrease) in cash and cash equivalents |
10,740 | (4,669 | ) | ||||||
Cash and cash equivalents at beginning of period |
32,111 | 44,795 | |||||||
Cash and cash equivalents at end of period |
$ | 42,851 | $ | 40,126 | |||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
IXYS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Condensed Consolidated Financial Statements
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The condensed consolidated financial statements include the accounts of IXYS Corporation (IXYS or the Company) and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation. All adjustments of a normal recurring nature that, in the opinion of management, are necessary for a fair statement of the results for the interim periods have been made. It is recommended that the interim financial statements be read in conjunction with the Companys audited consolidated financial statements and notes thereto for the fiscal year ended March 31, 2002 contained in the Companys Annual Report on Form 10-K. Interim results are not necessarily indicative of the operating results expected for later quarters or the full fiscal year. Certain reclassifications have been made to the prior periods condensed consolidated financial statements to conform to the current periods presentation. Such reclassifications had no effect on previously reported results of operations or retained earnings.
Effective as of the beginning of the first quarter of fiscal year 2003, the Company completed the adoption of Statement of Financial Accounting Standards (SFAS) No. 141 (SFAS 141), Business Combinations, and SFAS No. 142 (SFAS 142), Goodwill and Other Intangible Assets. SFAS 141 requires all business combinations initiated after June 30, 2001 to be accounted for using the purchase method of accounting. As required by SFAS 142, the Company discontinued amortizing the remaining balance of goodwill as of the beginning of fiscal year 2003. All remaining and future acquired goodwill will be subject to impairment tests, annually or earlier if indicators of potential impairment exist, using a fair-value-based-approach. All other intangible assets will continue to be amortized over their estimated useful lives and assessed for impairment under SFAS No. 144, Accounting for the impairment of Disposal of Long-lived Assets. In conjunction with the implementation of SFAS 142, the Company has completed a goodwill impairment review as of the beginning of fiscal year 2003 and found no impairment. Had SFAS 142 been implemented at the beginning of the first quarter of fiscal year 2002, the pro forma effect of excluding goodwill amortization expense would have been as follows:
| 3 Months Ended | |||||
| June 30, 2001 | |||||
|
|
|||||
| Reported net income | $ 1,586 | ||||
| Add back: Goodwill amortization | 58 | ||||
|
|
|||||
| Pro forma net income | $ 1,644 | ||||
|
|
|||||
| Reported net income per share | |||||
| Basic income per common share | $ 0.06 | ||||
| Diluted income per common share | $ 0.05 | ||||
| Add back: Goodwill amortization per share | |||||
| Basic income per common share | $ 0.00 | ||||
| Diluted income per common share | $ 0.01 | ||||
| Pro forma net income per share | |||||
| Basic income per common share | $ 0.06 | ||||
| Diluted income per common share | $ 0.06 |
2. Foreign Currency Translation
The local currency is considered to be the functional currency of IXYS wholly owned foreign subsidiaries. Accordingly, assets and liabilities are translated at the exchange rate in effect at period-end and revenues and expenses are translated at average rates during the period. Adjustments resulting from the translation of the accounts of IXYS foreign subsidiaries into U.S. dollars are included in cumulative translation adjustment, a separate component of stockholders equity. Foreign currency transaction gains and losses are included as a component of non-operating income and expense.
5
3. Acquisition of Clare, Inc.
On June 10, 2002, IXYS completed its acquisition of Clare, Inc. (Clare). The acquisition of Clare was intended to allow the combined organization to be more competitive and to achieve greater financial strength, operational efficiencies, access to capital and growth potential than either company could separately achieve. In connection with the acquisition, (a) each outstanding share of Clare common stock was converted into the right to receive 0.49147 of a share of IXYS common stock, which will result in the issuance of approximately 4.9 million shares of IXYS common stock, and (b) each option to purchase Clare common stock outstanding immediately prior to the consummation of the acquisition was converted into an option to purchase 0.49147 of a share of IXYS common stock, resulting in the assumption of options exercisable for approximately 1.0 million shares of IXYS Common Stock.
The estimated total purchase price is as follows (in thousands):
| Value of IXYS common stock issued | $47,658 | |||
| Value of IXYS options issued | 3,676 | |||
| Estimated direct merger costs | 1,722 | |||
|
|
||||
| Total purchase price | $53,056 | |||
|
|
IXYS is in the process of determining the fair values of identifiable intangible assets acquired and plant and equipment. IXYS is in the process of determining reasonable replacement costs to determine the fair value of plant and equipment acquired. IXYS is further determining the benefits achievable from contractual agreements to determine their fair value at the acquisition date. Based on preliminary estimates and draft valuations, IXYS preliminarily allocated the purchase price to identifiable intangible assets, tangible assets, liabilities assumed and goodwill as follows (in thousands):
Fair value of tangible assets acquired: |
|||||||||
Current assets |
$ | 24,861 | |||||||
Deferred tax assets, short term |
2,742 | ||||||||
Plant and equipment |
13,613 | ||||||||
Other assets |
111 | ||||||||
| $ | 41,327 | ||||||||
Amortizable intangible assets: |
Estimated useful lives | ||||||||
Contractual agreement |
3,100 | 3 years | |||||||
Core technology |
2,700 | 5 to 6 years | |||||||
Tradename / Trademarks |
900 | 3 years | |||||||
Other |
440 | 3 months to 6 years | |||||||
| 7,140 | |||||||||
Total assets acquired |
48,467 | ||||||||
Fair value of liabilities assumed |
(7,941 | ) | |||||||
Net assets acquired |
40,526 | ||||||||
Goodwill |
12,530 | ||||||||
Total purchase price |
$ | 53,056 | |||||||
6
Pro Forma Disclosure (in thousands, except per share data):
The following unaudited pro forma combined amounts give effect to the acquisition of Clare as if the acquisitions had occurred on April 1, 2002 and 2001. On a pro forma basis, the results of operations of Clare for the three-month periods ended June 30, 2002 and 2001 are consolidated with IXYS results for the three-month periods ended June 30, 2002 and 2001. The pro forma amounts do not purport to be indicative of what would have occurred had the acquisition been made as of the beginning of each period or of results which may occur in the future.
| Three Months Ended | ||||||||
| June 30, | ||||||||
| < | ||||||||